Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 10 Announcement Summary Entity name LUMOS DIAGNOSTICS HOLDINGS LIMITED Announcement Type New announcement Date of this announcement Tuesday July 28, 2026 The +securities to be...
Application for quotation of securities - LDX
Filed with ASX ·
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call6ix hasn’t read this filing yet.
Lumos Diagnostics Holdings Ltd. on 6ix
In the deck
Earlier from Lumos Diagnostics
- FebriDx Commercial Traction Across Priority US Accounts
- FebriDx U.S. Rollout and Reimbursement Update - Amended
- FebriDx U.S. Rollout and Reimbursement Update
- FebriDx Paediatric Study Enrolment Milestone Achieved
- Response to ASX Aware Letter
Later from Lumos Diagnostics
- Section 708A Cleansing Statement
- Change of Director's Interest Notice - DW
- Lumos Secures Distribution for FebriDx in Romania
- Lumos Receives FebriDx Order from PHASE Scientific
- Lumos to Present at 20th Bioshares Biotech Summit
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics